Reduced expression of Nogo-A leads to motivational deficits in rats

Frontiers in Behavioral Neuroscience

Volumn 8, Issue JAN, 2014, Pages

  Enkel, Thomas ^a   Berger, Stefan M ^a   Schönig, Kai ^a   Tews, Björn ^b   Bartsch, Dusan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Anhedonia; Avolition; Dopamine; Motivation; Nogo A; Reward sensitivity; Schizophrenia; Serotonin

Indexed keywords

DOPAMINE; MONOAMINE; PROTEIN NOGO A; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEEDING BEHAVIOR; MALE; MOTIVATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OPERANT BEHAVIORAL TEST; PREFRONTAL CORTEX; PREPULSE INHIBITION; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SHORT TERM MEMORY; SYMPTOMATOLOGY; WILD TYPE;

EID: 84893013758     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00010     Document Type: Article

References (40)

1. Barr, A. M., and Phillips, A. G. (1998). Chronic mild stress has no effect on responding by rats for sucrose under a progressive ratio schedule. Physiol. Behav. 64, 591-597. doi: 10.1016/S0031-9384(98)00060-2
2. Brown, R. G., and Pluck, G. (2000). Negative symptoms: the "pathology" of motivation and goal-directed behaviour. Trends Neurosci. 23, 412-417. doi:10.1016/S0166-2236(00)01626-X
3. Costantini, F., and D'Amato, F. R. (2006). Ultrasonic vocalizations in rats and mice: social contexts and functions. Acta Zool. Sin. 52, 619-633.
4. Cressant, A., Besson, M., Suarez, S., Cormier, A., and Granon, S. (2007). Spatial learning in Long-Evans Hooded rats and C57BL/6J mice: different strategies for different performance. Behav. Brain Res. 177, 22-29. doi:10.1016/j.bbr.2006.11.010
5. Dean, B. (2003). The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J. Neurochem. 85, 1-13. doi:10.1046/j.1471-4159.2003.01693.x
6. Dominguez, M. D., Saka, M. C., Lieb, R., Wittchen, H. U., and van Os, J. (2010). Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am. J. Psychiatry 167, 1075-1082. doi:10.1176/appi.ajp.2010.09060883
7. Enkel, T., Spanagel, R., Vollmayr, B., and Schneider, M. (2010). Stress triggers anhedonia in rats bred for learned helplessness. Behav. Brain Res. 209, 183-186. doi:10.1016/j.bbr.2010.01.042
8. Faure, A., Richard, J. M., and Berridge, K. C. (2010). Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS ONE 5:e11223. doi:10.1371/journal.pone.0011223
9. Hodos, W. (1961). Progressive ratio as a measure of reward strength. Science 134, 943-944. doi:10.1126/science.134.3483.943
10. Hodos, W., and Kalman, G. (1963). Effects of increment size and reinforcer volume on progressive ratio performance. J. Exp. Anal. Behav. 6, 387-392. doi:10.1901/jeab.1963.6-387
11. Huber, A. B., Weinmann, O., Brosamle, C., Oertle, T., and Schwab, M. E. (2002). Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22, 3553-3567.
12. Kempf, A., and Schwab, M. E. (2013). Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda) 28, 151-163. doi:10.1152/physiol.00052.2012
13. Keshavan, M. S., Tandon, R., Boutros, N. N., and Nasrallah, H. A. (2008). Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophr. Res. 106, 89-107. doi:10.1016/j.schres.2008.07.020
14. Kristofikova, Z., Vrajova, M., Sirova, J., Vales, K., Petrasek, T., Schonig, K., et al. (2013). N-Methyl-d-Aspartate receptor-nitric oxide synthase pathway in the cortex of Nogo-A-deficient rats in relation to brain laterality and schizophrenia. Front. Behav. Neurosci. 7:90. doi:10.3389/fnbeh.2013.00090
15. Le Pen, G., Gaudet, L., Mortas, P., Mory, R., and Moreau, J. L. (2002). Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology (Berl.) 161, 434-441. doi:10.1007/s00213-002-1092-4
16. Lewis, D. A., and Sweet, R. A. (2009). Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119, 706-716. doi:10.1172/JCI37335
17. McNamara, R. K., Namgung, U., and Routtenberg, A. (1996). Distinctions between hippocampus of mouse and rat: protein F1/GAP-43 gene expression, promoter activity, and spatial memory. Brain Res. Mol. Brain Res. 40, 177-187. doi:10.1016/0169-328X(96)00048-4
18. Messinger, J. W., Tremeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., et al. (2011). Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 31, 161-168. doi:10.1016/j.cpr.2010.09.002
19. Mingorance-Le Meur, A., Zheng, B., Soriano, E., and Del Rio, J. A. (2007). Involvement of the myelin-associated inhibitor Nogo-A in early cortical development and neuronal maturation. Cereb. Cortex 17, 2375-2386. doi:10.1093/cercor/bhl146
20. Mironova, Y. A., and Giger, R. J. (2013). Where no synapses go: gatekeepers of circuit remodeling and synaptic strength. Trends Neurosci. 36, 363-373. doi:10.1016/j.tins.2013.04.003
21. Mobini, S., Chiang, T. J., Ho, M. Y., Bradshaw, C. M., and Szabadi, E. (2000). Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology (Berl) 152, 47-54. doi:10.1007/s002130000486
22. Ngan, E. T., Yatham, L. N., Ruth, T. J., and Liddle, P. F. (2000). Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [(18)F]setoperone. Am. J. Psychiatry 157, 1016-1018. doi:10.1176/appi.ajp.157.6.1016
23. Nonkes, L. J., Tomson, K., Maertin, A., Dederen, J., Maes, J. H., and Homberg, J. (2010). Orbitofrontal cortex and amygdalar over-activity is associated with an inability to use the value of expected outcomes to guide behaviour in serotonin transporter knockout rats. Neurobiol. Learn. Mem. 94, 65-72. doi:10.1016/j.nlm.2010.04.002
24. Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates. London: Elsevier.
25. Petrasek, T., Prokopova, I., Bahnik, S., Schonig, K., Berger, S., Vales, K., et al. (2014). Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze. Neurobiol. Learn. Mem. 107, 42-49. doi:10.1016/j.nlm.2013.10.015
26. Poole, T. B., and Fish, J. (1975). An investigation of playful behaviour in Rattus norvegicus and Mus musculus (Mammalia). J. Zool. 175, 61-71. doi:10.1111/j.1469-7998.1975.tb01391.x
27. Reilly, S. (1999). Reinforcement value of gustatory stimuli determined by progressive ratio performance. Pharmacol. Biochem. Behav. 63, 301-311. doi:10.1016/S0091-3057(99)00009-X
28. Salamone, J. D., and Correa, M. (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron 76, 470-485. doi:10.1016/j.neuron.2012.10.021
29. Salamone, J. D., Correa, M., Farrar, A., and Mingote, S. M. (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl.) 191, 461-482. doi:10.1007/s00213-006-0668-9
30. Sanders, A. C., Hussain, A. J., Hen, R., and Zhuang, X. (2007). Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward. Neuropsychopharmacology 32, 2321-2329. doi:10.1038/sj.npp.1301368
31. Schneider, M., Heise, V., and Spanagel, R. (2010). Differential involvement of the opioid receptor antagonist naloxone in motivational and hedonic aspects of reward. Behav. Brain Res. 208, 466-472. doi:10.1016/j.bbr.2009.12.013
32. Schneider, M., and Koch, M. (2005). Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Exp. Neurol. 195, 185-198. doi:10.1016/j.expneurol.2005.04.014
33. Schwab, M. E. (2010). Functions of Nogo proteins and their receptors in the nervous system. Nat. Rev. Neurosci. 11, 799-811. doi:10.1038/nrn2936
34. Strauss, G. P., and Gold, J. M. (2012). A new perspective on anhedonia in schizophrenia. Am. J. Psychiatry 169, 364-373. doi:10.1176/appi.ajp.2011.11030447
35. Tandon, R., Keshavan, M. S., and Nasrallah, H. A. (2008). Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res. 102, 1-18. doi:10.1016/j.schres.2008.04.011
36. Tandon, R., Nasrallah, H. A., and Keshavan, M. S. (2009). Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 110, 1-23. doi:10.1016/j.schres.2009.03.005
37. Tews, B., Schonig, K., Arzt, M. E., Clementi, S., Rioult-Pedotti, M. S., Zemmar, A., et al. (2013). Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc. Natl. Acad. Sci. U.S.A. 110, 6583-6588. doi:10.1073/pnas.1217665110
38. Willi, R., Aloy, E. M., Yee, B. K., Feldon, J., and Schwab, M. E. (2009). Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A. Genes Brain Behav. 8, 181-192. doi:10.1111/j.1601-183X.2008.00460.x
39. Willi, R., and Schwab, M. E. (2013). Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol. Dis. 54, 150-157. doi:10.1016/j.nbd.2013.01.011
40. Willi, R., Weinmann, O., Winter, C., Klein, J., Sohr, R., Schnell, L., et al. (2010). Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J. Neurosci. 30, 556-567. doi:10.1523/JNEUROSCI.4393-09.2010